Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 27080498

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2016 Jun 11
First author
Ribrag V

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Jun 11;387(10036):2360-1. doi: 10.1016/S0140-6736(16)00164-1.
    note
    Source null
    related pmid
    27080497
    relationship
    Comment in

Authors and identifiers

  1. name
    Ribrag V
    type
    Author
  2. name
    Koscielny S
    type
    Author
  3. name
    Bosq J
    type
    Author
  4. name
    Leguay T
    type
    Author
  5. name
    Casasnovas O
    type
    Author
  6. name
    Fornecker LM
    type
    Author
  7. name
    Recher C
    type
    Author
  8. name
    Ghesquieres H
    type
    Author
  9. name
    Morschhauser F
    type
    Author
  10. name
    Girault S
    type
    Author
  11. name
    Le Gouill S
    type
    Author
  12. name
    Ojeda-Uribe M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ribrag V
    type
    Author
  2. name
    Koscielny S
    type
    Author
  3. name
    Bosq J
    type
    Author
  4. name
    Leguay T
    type
    Author
  5. name
    Casasnovas O
    type
    Author
  6. name
    Fornecker LM
    type
    Author
  7. name
    Recher C
    type
    Author
  8. name
    Ghesquieres H
    type
    Author
  9. name
    Morschhauser F
    type
    Author
  10. name
    Girault S
    type
    Author
  11. name
    Le Gouill S
    type
    Author
  12. name
    Ojeda-Uribe M
    type
    Author
bibliography ids
  1. nci-bib-15af5a74f6a5c9022055860e
book metadata
content sha256
82eb449d560f77a584335213df19566fa7d85f53a6c54ddbe0fbac459a221570
document type
citation
dois
  1. 10.1016/S0140-6736(15)01317-3
electronic publication date
display
2016 Apr 11
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27080498
immutable id
pubmed:27080498@82eb449d560f77a584335213df19566fa7d85f53a6c54ddbe0fbac459a221570
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10036
name
Lancet (London, England)
nlm unique id
2985213R
pages
2402-11
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Jun 11;387(10036):2360-1. doi: 10.1016/S0140-6736(16)00164-1.
    note
    Source null
    related pmid
    27080497
    relationship
    Comment in
outcomes validated
false
pmid
27080498
provenance
batch id
fe5a46c92522c34737e8
provider
NCBI PubMed ESummary
record sha256
01261314a2f650984463d2f99d5fe0b9d9579932ab06b73026145b9a3b3291b7
response sha256
2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
retrieved at
2026-09-09T23:47:17.939307+00:00
publication date
display
2016 Jun 11
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27080498/
title
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.

Preserved source evidence · Independent clinical review pending · Not medical advice